Somatic mosaicism for a heterozygous deletion of the survival motor neuron (SMN1) gene

Eur J Hum Genet. 2005 Mar;13(3):309-13. doi: 10.1038/sj.ejhg.5201268.

Abstract

Infantile spinal muscular atrophy (SMA) is a common autosomal recessive disease with a high demand for carrier testing. The disease is caused by homozygous deletions of the survival motor neuron (SMN)1 gene on chromosome 5q13 in more than 90% of cases. Meanwhile, several reliable quantitative methods for carrier detection in the general population have been implemented with a risk of at least 5% for false negative results. Linkage analyses with chromosome 5 markers can be used for complementary information, but they are restricted to risk estimation of close relatives in affected families. Here, we present the first observation of a somatic mosaicism in an SMA carrier. Molecular genetic studies gave evidence that the SMN1 deletion of an SMA type I patient most probably arose from somatic mosaicism in the paternal grandmother. The patient's father and his two brothers were shown to be carriers of three different maternal haplotypes in 5q13. Final conclusions for genetic counselling were only possible after both linkage analysis and quantitative real-time PCR analysis of SMN1 copy numbers.

MeSH terms

  • Chromosomes, Human, Pair 5 / genetics
  • Cyclic AMP Response Element-Binding Protein / genetics*
  • Female
  • Gene Deletion*
  • Genetic Carrier Screening / methods*
  • Genetic Counseling
  • Heterozygote
  • Humans
  • Male
  • Mosaicism*
  • Nerve Tissue Proteins / genetics*
  • Pedigree
  • Polymerase Chain Reaction
  • RNA-Binding Proteins / genetics*
  • SMN Complex Proteins
  • Spinal Muscular Atrophies of Childhood / genetics*
  • Survival of Motor Neuron 1 Protein

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Nerve Tissue Proteins
  • RNA-Binding Proteins
  • SMN Complex Proteins
  • SMN1 protein, human
  • Survival of Motor Neuron 1 Protein